EMBECTA CORP. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
EMBECTA CORP. (EMBC) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $14.20 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-07
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $14.20M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $15.40M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $16.90M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $18.60M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-06-30 | $14.20M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $15.40M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $16.90M 10-Q · filed 2026-02-05 |
| 2025-09-30 | $18.60M 10-K · filed 2025-11-25 |
| 2025-06-30 | $20.80M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $22.90M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $24.70M 10-Q · filed 2025-02-06 |
| 2024-09-30 | $26.50M 10-K · filed 2024-12-11 |
| 2024-06-30 | $28.30M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $29.70M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $31.00M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $32.40M 10-K · filed 2023-11-29 |
| 2023-06-30 | $33.60M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $35.00M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $36.30M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $37.70M 10-K · filed 2022-12-22 |
| 2022-06-30 | $38.90M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $36.80M 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |